Formulated to support synthetic operations, the Hplc Column Nucleodur ® C 8 Gravity, 3 μm, 50 mm, 4 mm features a reversed phase (RP) separation principle and a high density C 8 phase based on high purity NUCLEODUR ® silica gel. Endcapped to suppress unwanted polar interactions, this column is ideal for separating basic and other ionizable analytes, making it a valuable asset for RP applications. With a particle size of 3 μm, it offers pressure stability up to 600 bar and temperature stability up to 60 °C. Its specific surface area according to BET is 340 m²/g, ensuring efficient separation. The column's recommended applications include pharmaceuticals, antidepressants, anti-inflammatory drugs, herbicides, and more, making it an

• Category: Separation columns for HPLC
• Temperature stability: 60 ° C
• Pressure stability: 600 bar
• Endcapped: yes
• Surface chemistry: Base deactivated (BDS), High density monomeric octyl (C 8 , MOS) modification
• Column shape: Analytical separation column
• Specific surface according to BET: 340 m²/g
• Similar phases: NUCLEOSIL ® C 8 HD Xterra ® RP 8 / MS C 8 Luna ® C 8 Zorbax ® Eclipse XDB-C 8
• Column type: HPLC column
• Phase: C 8 Gravity
• Separation principle: Reversed phase (RP)
• Particle type: Fully porous particles (FPP)
• USP listing: L7
• Interactions / retention mechanism: hydrophobic (van der Waals)
• Pore volume: 0.9 ml/g
• L x Ø internal (column): 50 x 4 mm
• Eluent in column: Acetonitrile - Water
• Particle size: 3 µm
• Column volume: 0.62 ml
• Recommended application(s): In general compounds with ionizable functional groups such as basic pharmaceuticals and pesticides Analgesics Antidepressants Applications for extreme pH values (1-11) Anti-inflammatory drugs Herbicides Ideal for method development Immunosuppressants Pharmaceutical products Phytopharmaceuticals
• pH stability: 1,0-11,0
• Pore size: 110 Å